ArticleKidney international reports2026
Immunofluorescence Patterns in IgAN are Associated With Active, Necrotizing Lesions.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: IgA nephropathy (IgAN) is characterized by profound heterogeneity, yet therapeutic decisions often rely on a "1-size-fits-all" strategy. As the therapeutic landscape expands to include B-cell and complement-targeting agents, a better understanding of underlying disease mechanisms is increasingly important. This study aimed to identify distinct immunological endotypes and determine their associations with severe, active histological lesions - particularly glomerular necrosis - to guide precision medicine. Methods: We performed a comprehensive retrospective analysis of 284 patients with biopsy-proven IgAN from the Magdeburg Biopsy Registry (2010-2023). Patients with secondary forms of IgAN, including lupus nephritis and infection-associated glomerulonephritis, were strictly excluded. The cohort was characterized by a high burden of advanced disease, reflected by reduced estimated glomerular filtration rate (eGFR) at the time of diagnosis and a high prevalence of chronic histopathological changes on kidney biopsy. Beyond standard mesangial hypercellularity, endocapillary hypercellularity, segmental glomerulosclerosis, tubular atrophy/interstitial fibrosis, and crescents (MEST-C) scoring, we stratified patients into 3 immunofluorescence endotypes as follows: (i) "classic" (IgA, IgM, C3, C1q); (ii) "full-house" (classic + IgG); and (iii) "complement" (IgA + C3/C1q, negative for IgG/IgM). Multivariable logistic regression was used to isolate factors associated with glomerular necrosis. Results: The "full-house" pattern (26.1%) emerged as a highly aggressive phenotype, showing a 30.1% prevalence of glomerular necrosis - 5 times higher than the "classic" pattern. In multivariable analysis, the "full-house" pattern was the most powerful independent factor associated with necrosis (odds ratio [OR]: 11.32; 95% confidence interval [CI]: 4.17-30.72; Conclusion: Immunohistological subtyping unmasks critical endotypes in IgAN that MEST-C scores alone may miss. The "full-house" pattern is a robust marker for necrotizing lesions, potentially driven by IgG-mediated classical pathway activation, whereas the "complement" pattern signals advanced functional loss. These findings improve the biological characterization of IgAN and identify distinct immunopathological subgroups associated with disease severity. Their potential relevance for treatment stratification remains hypothesis-generating and requires validation in prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.